Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01681082
Other study ID # SE-2012-0539
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2012
Est. completion date May 2014

Study information

Verified date December 2015
Source University of Wisconsin, Madison
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The general purpose of this study is to examine the effect of tai chi training on cognitive function in young adults. The investigators will test subjects enrolled in a semester-long tai chi course along with control subjects. The specific aims are to measure duration of practice, cognitive function, physical balance, and Attention Deficit Hyperactivity Disorder (ADHD) indicators. The investigators primary hypotheses are that, compared to controls, subjects in the tai chi course will show improvements in (1a) spatial working memory and (1b) response inhibition. The investigators secondary hypotheses are that, among the subjects participating in the tai chi course, these cognitive improvements will correlate with (2a) improvements in balance and (2b) duration of tai chi practice, and that, among all participants, (2c) ADHD indications will correlate with cognitive measures.


Recruitment information / eligibility

Status Completed
Enrollment 161
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 23 Years
Eligibility Inclusion Criteria: - Able to perform balance and cognitive tests Exclusion Criteria:

Study Design


Related Conditions & MeSH terms

  • Attention Deficit Disorder With Hyperactivity

Intervention

Behavioral:
Tai Chi training
24 form Yang style Tai Chi. 50 minute sessions, twice weekly.

Locations

Country Name City State
United States University of Wisconsin-Madison, Waisman Center Madison Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

References & Publications (1)

Converse AK, Ahlers EO, Travers BG, Davidson RJ. Tai chi training reduces self-report of inattention in healthy young adults. Front Hum Neurosci. 2014 Jan 27;8:13. doi: 10.3389/fnhum.2014.00013. eCollection 2014. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in working memory CANTAB Spatial Working Memory Task: SWM between errors Baseline and 14 weeks
Secondary Change in physical balance One Legged Stance Test. Time standing on one leg with eyes closed. Average over left and right leg of best of three trials on each side. Baseline and 14 weeks
Secondary Change in impulsivity CANTAB Stop Signal Task: reaction time (SSRT). Baseline and 14 weeks
Secondary Change in affective processing CANTAB Affective Go/No-Go Task: mean correct latency Baseline and 14 weeks
Secondary Change in attention deficit hyperactivity disorder (ADHD) scale World Health Organization adult ADHD self-report scale (ASRS). Scoring of 6 item ASRS screener per Kessler et al. Psychological Medicine (2005) 35:245-256. Baseline and 14 weeks
Secondary Duration of practice Total minutes of tai chi practice including class time. 14 weeks
See also
  Status Clinical Trial Phase
Completed NCT00202605 - Safety and Efficacy of SPD465 in Adults With ADHD Phase 2
Not yet recruiting NCT02677519 - A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD Phase 4
Completed NCT02730572 - Concerta (Methylphenidate) -To-Generic Switch Study N/A
Active, not recruiting NCT01330693 - Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy Phase 3
Completed NCT00830700 - Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study N/A
Completed NCT01012622 - An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) Phase 4
Completed NCT00626236 - Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems Phase 2
Completed NCT00598182 - Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study N/A
Completed NCT00381407 - Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00247572 - Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories Phase 2
Completed NCT00178503 - Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children Phase 2/Phase 3
Completed NCT00218322 - Effectiveness of ATMX in Treating Adolescents With ADHD and SUD Phase 4
Completed NCT00118911 - Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder N/A
Completed NCT00557011 - NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD Phase 2
Completed NCT00071656 - Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I N/A
Active, not recruiting NCT00057668 - Preventing Behavior Problems in Children With ADHD Phase 2
Completed NCT00050622 - Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT00050050 - Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder Phase 1
Completed NCT00031395 - Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children Phase 3
Completed NCT00000388 - Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) Phase 4

External Links